Clinical trial
Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of…
NCT00117949 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00117949 |
|---|---|
| Title | Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 |
| Official title | An Open-Label, Multi-Center, Ascending, Single Dose Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Degarelix |
| Enrollment | 82 |
| Start date | Apr 1, 2002 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Jul 11, 2005 |
| Last update posted | May 23, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: